Prescription price controls induce shortages and hamper innovation

Lately, stakeholders in the health economy have been playing the “blame game” over rising healthcare expenses. Price controls have taken center stage in state and federal proposals as a tactic to arbitrarily lower prescription drug costs.

While this may seem like a reasonable solution to an issue we all face, price controls wherever and whenever they have been tried always have undesirable short- and long-term economic consequences. Misguided and ill-informed policies like these will harm patients here in Connecticut and across the nation.